Loading...
Last update:  December 3, 2017
19:22 +1GMT

Allergenic Molecule  Cor a 8Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
4.1.5 - Heterologous Source Sensitized (IgE)2011ItalyIgE43136.66020111123, Bernardi ML
6.2 - General Population (Adults)2012SwedenIgE3710.00020120528, Patelis A
1.5 - Atopic Dermatitis, Diagnosed2014NetherlandsIgE2115.20020140331, Rockmann H
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1409.29020130111, Ott H
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2014SpainIgE13041.60020140401, Armentia A
1.3 - Rhinitis, Diagnosed2013BrazilIgE1010.00020130912, Lacerda Araujo LM
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE995.05020110223, De Knop KJ
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE960.00020120528, Patelis A
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8616.27020101214, Gadisseur R
4.1.1 - Heterologous Source Sensitized (Symptoms)2013NetherlandsIgE823.66020130415, Masthoff LJ
3.1.1 - Source Sensitized (SPT)2012SpainIgE7973.42020121016, Javaloyes G
5.1.1 - Source Exposed (Symptoms)2013NetherlandsIgE796.33020130415, Masthoff LJ
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE761.30020131020, van Rhijn BD
4.1.8 - Heterologous Source Sensitized (SPT, IgE)2012SpainIgE6816.20020120726, Pedrosa M
1.11 - Esophagitis, Diagnosed2014SpainIgE6717.90020140625, Armentia A
5.7.2 - Source Exposed (Provocation Test - Ingestion)2004Germany / SwitzerlandIgE (IB)650.000
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2012SpainIgE5536.40020120726, Pedrosa M
1.1 - Asymptomatic2014SpainIgE500.00020140625, Armentia A
1.9 - Pollen Allergy2014SpainIgE504.00020140625, Armentia A
5.2.4 - Source Exposed, Adults (Symptoms, IgE)2012NetherlandsIgE4211.90020120905, Le TM
1.12 - Oral Allergy Syndrome2014BelgiumIgE382.63020140718, Faber MA
1.6 - Anaphylaxis, Diagnosed2014BelgiumIgE3716.21020140718, Faber MA
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE375.40520090826, Ebo DG
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE355.71020130605, Simon D
3.2.1 - Source Sensitized (IgE)2014United StatesIgE2920.70020140606, Kattan JD
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009ItalyIgE2650.00020091204, Ciardiello MA
5.2.1 - Source Exposed (Symptoms, SPT)2004SpainIgE (IB)2661.500
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010SpainIgE2684.61020100618, Hartz C
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE220.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009DenmarkIgE210.00020090406, Skamstrup Hansen K
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009ItalyIgE2138.09020090808, Krause S
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009SwitzerlandIgE210.00020090406, Skamstrup Hansen K
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2040.00020091005, Ott H
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE200.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009SpainIgE2020.00020090406, Skamstrup Hansen K
5.3.1 - Source Exposed (Symptoms, IgE)2010BelgiumIgE200.00020100628, Verweij MM
5.7.2 - Source Exposed (Provocation Test - Ingestion)2009DenmarkIgE205.00020090406, Skamstrup Hansen K
5.7.2 - Source Exposed (Provocation Test - Ingestion)2009SwitzerlandIgE2015.00020090406, Skamstrup Hansen K
5.7.2 - Source Exposed (Provocation Test - Ingestion)2009SpainIgE1771.00020090406, Skamstrup Hansen K
5.7.2 - Source Exposed (Provocation Test - Ingestion)2003Denmark / SwitzerlandIgE (IB)170.000
1.1 - Asymptomatic2014BelgiumIgE156.67020140718, Faber MA
10.1 - Normal Control2014BelgiumIgE150.00020140718, Faber MA
1.5 - Atopic Dermatitis, Diagnosed2014BelgiumIgE140.00020140718, Faber MA
5.3.1 - Source Exposed (Symptoms, IgE)2014United StatesIgE1346.20020140606, Kattan JD
Developed by
Panservice